Industry
Medical - Healthcare Information Services
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
Loading...
Open
2.25
Mkt cap
20M
Volume
122K
High
2.39
P/E Ratio
-2.71
52-wk high
8.35
Low
2.05
Div yield
N/A
52-wk low
1.43
Portfolio Pulse from Benzinga Insights
October 18, 2024 | 4:31 pm
Portfolio Pulse from Benzinga Newsdesk
October 18, 2024 | 4:30 pm
Portfolio Pulse from Benzinga Newsdesk
October 18, 2024 | 1:33 pm
Portfolio Pulse from Benzinga Newsdesk
October 09, 2024 | 1:25 pm
Portfolio Pulse from Benzinga Newsdesk
October 09, 2024 | 11:38 am
Portfolio Pulse from Avi Kapoor
September 24, 2024 | 12:51 pm
Portfolio Pulse from Benzinga Newsdesk
July 25, 2024 | 11:40 am
Portfolio Pulse from Benzinga Newsdesk
June 21, 2024 | 2:39 pm
Portfolio Pulse from Benzinga Insights
June 14, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
May 16, 2024 | 12:18 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.